ArticleFrontiers in immunology2025

Zanubrutinib plus R-CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2.

Min Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.